"Post-Polycythemia Vera Myelofibrosis (PPV-MF) - Pipeline Review, H2 2012" Published
Global Markets Direct's, 'Post-polycythemia vera myelofibrosis (PPV-MF) - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Post-polycythemia vera myelofibrosis (PPV-MF), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Post-polycythemia vera myelofibrosis (PPV-MF). Post-polycythemia vera myelofibrosis (PPV-MF) - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's...
View full press release